홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

나파졸린

Naphazoline

HCID 4436
새 반응
인쇄
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
10061-11-7
표준 SMILES
c1ccc2c(CC3=NCCN3)cccc2c1
InChIKey
CNIIGCLFLJGOGP-UHFFFAOYSA-N
분자식
C14H14N2
평균 분자량
210.27 g/mol
단동위원소 질량
210.11569846

개요

2-(1-naphthalenylmethyl)-4,5-dihydro-1H-imidazole is a member of naphthalenes.

이름 및 식별자

우선 이름
Naphazoline
IUPAC
2-(naphthalen-1-ylmethyl)-4,5-dihydro-1H-imidazole
현지명
나파졸린
영어명
Naphazoline
분자식
C14H14N2
분자량
210.27

이름 및 동의어

naphazoline835-31-42-(naphthalen-1-ylmethyl)-4,5-dihydro-1H-imidazoleNafazolinaClearineNafazolinNaphazolinum2-(1-Naphthylmethyl)-2-imidazolineCiba 2020/Ralpha-Naphthylmethyl imidazoline1H-Imidazole, 4,5-dihydro-2-(1-naphthalenylmethyl)-DTXSID3048449
이름 더 보기
나파졸린나파졸린및그염류NAPHAZOLINE HCLNAFAZOLINENaphazoline-d42-(1-NAPHTHYLMETHYL)-2-IMIDAZOLINE HYDROCHLORIDEAntanImidinPrivineSanorinRhinazineciba2020/r
H231GF11BVDTXCID90198485Tele StullnAK ConVasoconstrictor PensaPensa, VasoconstrictorRefChem:56335naphthizinum (for the nitrate)

데이터베이스 식별자

CAS
10061-11-7、835-31-4
PubChem CID
4436
DTXSID
DTXSID3048449
ChEMBL
CHEMBL761
ChEBI
CHEBI:93363
UNII
H231GF11BV
EC Number
212-641-5、233-197-9
Nikkaji
J7.133A

물성

구조 계산 물성

XLogP
2.1
극성 표면적
24.4 Ų
수소 결합 공여자 수
1
수소 결합 수용자 수
1
회전 가능 결합 수
2
무거운 원자 수
16
형식 전하
0
복잡도
272

실험 및 물리화학적 성질

DrugsPharmaceuticals -> Listed in ZINC15
Animal DrugsPharmaceuticals -> Animal Drugs -> Approved in Taiwan
Physical DescriptionSolid
Collision Cross Section · 2건

149.6 Ų [M+H]+ [CCS Type: TW; Method: Major Mix IMS/Tof Calibration Kit (Waters)]

147.59 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

물리화학적 성질

녹는점
254 °C · 254 °C
끓는 점
339.81 °C · 339.81°C (rough estimate)
밀도
1.1063 · 1.1063 (rough estimate)
굴절률
1.618 · 1.6180 (estimate)
저장 조건
2 · 2-8°C
산도 계수 (pKa)
10.35 · pKa 10.35 ± 0.02(H2O,t =25,Iundefined) (Uncertain)
물리적 상태
Solid
색상
White to light yellow
NIST
Naphazoline(835-31-4)

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 3건

This chemical does not meet GHS hazard criteria for 100% (2 of 2) of all reports.

Not Classified

Aggregated GHS information provided per 2 reports by companies from 1 notifications to the ECHA C&L Inventory.

유해성 정보

Regulatory InformationREACH registered substance: Naphazoline (EC: 212-641-5)
Hazard Classes and CategoriesNot Classified

안전 데이터

wgk
3
rtecs
NJ4375000
ridadr
UN 2811 6.1/PG 2
risk_code
25
hazard_code
T
safety_code
45

화학 및 산업

약리 정보

ATC Code · 6건

R01AA08

S - Sensory organs

R - Respiratory system

R - Respiratory system

QR - Respiratory system

QR - Respiratory system

Protein BindingProtein binding data for naphazoline is unavailable.
PharmacodynamicsNaphazoline is a sympathomimetic alpha adrenergic agonist that acts to vasoconstrict nasal or ocular arterioles, resulting in reduced congestion at the site of administration.
Mechanism of Action · 1건

Naphazoline is a vasoconstrictor that functions by stimulating alpha adrenergic receptors in arterioles leading to decreased congestion at the site of administration. Naphazoline causes the release of norepinephrine in sympathetic nerves. Norepinephrine binds to alpha adrenergic receptors and causes vasoconstriction. Naphazoline is also a mild beta adrenergic receptor agonist, which can cause rebound vasodilation after the alpha adrenergic stimulation has ended. Naphazoline's release of norepinephrine also triggers a negative feedback loop which decreases production of norepinephrine, which can lead to rhinitis medicamentosa after long term use when naphazoline is stopped.

Biological Half-LifeHalf life has not been determined but effects last for 4 to 8 hours. Other imidazoline compounds have half lives varying from 2 to 12 hours.
Metabolism/MetabolitesMetabolism data for naphazoline are scarce. Imidazoline compounds undergo some hepatic metabolism but a large fraction of the dose may be excreted unchanged in the urine.
MeSH Pharmacological Classification · 2건

Drugs that selectively bind to and activate alpha adrenergic receptors.

Drugs designed to treat inflammation of the nasal passages, generally the result of an infection (more often than not the common cold) or an allergy related condition, e.g., hay fever. The inflammation involves swelling of the mucous membrane that lines the nasal passages and results in inordinate mucus production. The primary class of nasal decongestants are vasoconstrictor agents. (From PharmAssist, The Family Guide to Health and Medicine, 1993)

관련 반응

0건
반응 기록 만들기
아직 관련 반응이 없습니다

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
Absorption, Distribution and Excretion · 4건

Absorption data for naphazoline are scarce but imidazoline compounds in general are weakly basic and lipophilic, with high bioavailability from the gastrointestinal tract.

Imidazoline compounds undergo some hepatic metabolism but a large fraction of the dose may be excreted unchanged in the urine. Urinary excretion is higher with more acidic urine.

Distribution data for naphazoline are scarce but imidazoline compounds are distributed throughout the body, and can cross the blood-brain barrier.

Clearance data for naphazoline is unavailable.

Cellular LocationsMembrane

용도 및 제조

Use ClassificationPharmaceuticals -> Animal Drugs -> Approved in Taiwan

응용 분야

용도Naphazoline is used in severe rhinitis associated with colds, allergic reactions, and severe and chronic inflammatory conditions, in particular for inflammation of the antrum of Highmore as well as for stopping nosebleeds.

상·하류 제품 정보

상류 원료

메틸알콜에틸알코올에틸렌디아민1-Naphthalenol, 4-methylbenzenesulfonate1-나프틸아세토니트릴에틸렌디아민토실레이트Ethylenediamine monohydrate1-나프탈렌아세트산에탄올아민

하류 제품

N-(2-아미노에틸)-2-(1-나프틸)아세타미드Naphazoline nitrate